The promoter region of the cannabinoid receptor 1 (CNR1) gene, encoding the type 1 cannabinoid receptor, exhibited hypomethylation in the prefrontal cortex and peripheral blood mononuclear cells (PBMCs) of schizophrenia patients compared to control groups. This evidence concerns the gene CNR1 and schizophrenia.